U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07116499) titled 'A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of K-645 in the Treatment of Multiple Migraine Attacks' on Aug. 07.
Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled, 3-period crossover study to evaluate the safety, tolerability, and efficacy of two dose levels of K-645 in the treatment of patients with acute migraine.
Study Start Date: Aug. 07
Study Type: INTERVENTIONAL
Condition:
Acute Migraine
Intervention:
DRUG: Placebo
Single oral dose of matching placebo
DRUG: K-645 dose level 1
Single oral dose of K-645 dose level 1
DRUG: K-645 dose level 2
Single oral dose of K-645 ...